Floatz logo

FENTANYL

Analgesia

Aga Khan UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Analgesia cohort.

Asset / SponsorPhaseRating
NEPENTHE
Meri Mirceta
Phase 4BBB
LIDOCAINE
Meri Mirceta
Phase 4BB
DEXAMETHASONE
Meri Mirceta
Phase 4BB
ROPIVACAINE
Dr Kassiani Theodoraki
Phase 4BB
Vts-K
Theresa Jacob, PhD, MPH
Phase 4BB

View all 28 →

Same molecule, other indications

FENTANYL is also rated in:

Low Back PainDormant
BBB
Indicative ·
75 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →